Medicine
Cefepime 2 g powder for injection
Cefepime 2 g powder for injection is a generic prescription medicine for intravenous use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Cefepime for Injection, USP in the dry state should be stored at 20° to 25°C…
Key facts
- Active ingredient (INN)
- Cefepime
- Brand
- Sold under the generic name
- Strength
- 2 g
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 10 vials, 1 vial and 8 more
- Manufacturers
- ApotexHikma PharmaceuticalsWG Critical CareFresenius KabiHospiraQilu Pharmaceutical
- Origin register
- US FDA, United States
- Storage
- Cefepime for Injection, USP in the dry state should be stored at 20° to 25°C (68° to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DE01 Cefepime
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 August 2010
- Identifiers
- RxCUI 1665088, 1665093, 1665097DailyMed set ID e80c27e2-164d-4836-ba24-c160d75dc5d3, 5e1695e0-1310-4cd8-a5da-ad1a7dcd1792, d63d360a-15ec-44a4-b80d-b2a5cb5759eb +7NDC 0409-9735, 63323-340, 60505-6145 +7Application ANDA065441, ANDA203704, ANDA214402
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-dose in 1 carton / 1 injection, powder, for solution in 1 vial, single-dose | 60505-6145-4 | Apotex | 14 November 2017 |
| 1 vial, single-dose in 1 carton / 1 injection, powder, for solution in 1 vial, single-dose | 60505-6147-0 | Apotex | 30 March 2017 |
| 10 vial, single-dose in 1 carton / 1 injection, powder, for solution in 1 vial, single-dose | 60505-6147-4 | Apotex | 30 March 2017 |
| 10 vial, single-dose in 1 carton / 1 injection, powder, for solution in 1 vial, single-dose | 60505-6246-4 | Apotex | 1 September 2022 |
| 10 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 0143-9383-10 | Hikma Pharmaceuticals | 22 September 2025 |
| 10 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 0143-9478-10 | Hikma Pharmaceuticals | 31 October 2025 |
| 10 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 44567-131-10 | WG Critical Care | 31 March 2021 |
| 10 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 44567-241-10 | WG Critical Care | 10 October 2014 |
| 10 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 63323-340-20 | Fresenius Kabi | 30 August 2010 |
| 10 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 0409-9735-10 | Hospira | 24 August 2020 |
| 10 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 67184-1004-1 | Qilu Pharmaceutical | 1 February 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 January 1996 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cefepime
Clinical summary
Cefepime is a cephalosporin antibacterial indicated in the treatment of infections caused by susceptible isolates of the designated microorganisms, among other approved uses. It is available as powder for injection and injection for intravenous and intramuscular use. MedsAcross supplies Cefepime for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CefepimeFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cefepime prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Cefepime 2 g powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.